41.17
Novo Nordisk Adr 주식(NVO)의 최신 뉴스
Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom? - The Motley Fool
NVO Stock Price, Quote & Chart | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill
Novo Nordisk A/S stock (DK0062498333): Is its obesity drug dominance strong enough to sustain long-t - AD HOC NEWS
[6-K] NOVO NORDISK A S Current Report (Foreign Issuer) | NVO SEC FilingForm 6-K - Stock Titan
Novo Nordisk A/S stock (DK0062498333): Is obesity drug dominance strong enough to unlock new upside? - AD HOC NEWS
Novo Nordisk A/S stock (DK0062498333): Is obesity drug dominance strong enough to sustain growth? - AD HOC NEWS
Novo Nordisk A/S stock (DK0062498333): Is its obesity drug dominance strong enough to unlock new ups - AD HOC NEWS
Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake - Sahm
NVO Stock Quote Price and Forecast - CNN
NVO Forecast, Price Target & Analyst Ratings | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill
UBS (NYSE: UBS) offers autocallable notes tied to Novo Nordisk ADRs due 2027 - Stock Titan
UBS (AMUB) offers autocallable contingent-yield notes linked to Novo Nordisk ADRs - Stock Titan
Novo Nordisk A/S Sponsored ADR Class B Trade Ideas — BMV:NVO/N - TradingView
Novo Nordisk EVOKE Update Raises Questions On Growth Beyond Obesity And Diabetes - Sahm
Novo Nordisk Leans Into Obesity Care With ORION Data And Wegovy Pricing - Sahm
NVO News | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill
Novo Nordisk Wins EU Nod To Ease Wegovy Injection Delivery - Sahm
Novo Nordisk A/ S stock: Why it's still a powerhouse amid volatility - AD HOC NEWS
Novo Nordisk (NYSE: NVO) details progress in DKK 15B buyback - Stock Titan
Novo Nordisk A/ S stock: Weight-loss boom far from over — what investors need to know - AD HOC NEWS
Novo Nordisk A/S (NVO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Novo Nordisk Wegovy Subscription Targets Self Pay Demand And Investor Focus - Sahm
NVO Stock Chart | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill
Novo Nordisk A/S Stock: Navigating GLP-1 Leadership Amid Evolving Obesity Treatment Landscape - AD HOC NEWS
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan - Sahm
Novo Nordisk (NYSE: NVO) details progress on DKK 15bn share repurchase - Stock Titan
Novo Nordisk A/S Stock: Pipeline Innovations Amid Share Price Pressures and Market Challenges - AD HOC NEWS
Novo Nordisk Voucher Win Meets Rising Scrutiny Of FDA Review Program - Sahm
자본화:
|
볼륨(24시간):